by FiveSenses | Jan 31, 2025 | News Release
Montreal, QC, Canada, January 31, 2025 – Defence Therapeutics Inc. (“Defence” or the “Company”), (CSE: DTC, OTCQB: DTCFF, FSE: DTC) a Canadian biopharmaceutical company developing radiopharmaceuticals and ADC products using its proprietary platform and drug...
by FiveSenses | Jan 10, 2025 | News Release
Montreal, QC, Canada, January 10, 2025 – Defence Therapeutics Inc. (“Defence” or the “Company”), (CSE: DTC, OTCQB: DTCFF, FSE: DTC) a Canadian biopharmaceutical company developing radiopharmaceuticals and ADC products using its proprietary platform and drug...
by FiveSenses | Jan 6, 2025 | News Release
Vancouver, BC, Canada, January 6, 2025 – Defence Therapeutics Inc. (“Defence” or the “Company”), (CSE: DTC, OTCQB: DTCFF, FSE: DTC) a Canadian biopharmaceutical company developing radiopharmaceuticals and ADC products using its proprietary platform and drug...
Recent Comments